KNW
CLX icon

Kesler Norman & Wride’s Clorox CLX Stock Holding History

Kesler Norman & Wride’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,776
Closed -$289K – 222
2024
Q3 		$289K Sell
1,776
-1,053
-37% -$156K 0.06% 207
2024
Q2 		$386K Sell
2,829
-467
-14% -$64.9K 0.08% 149
2024
Q1 		$505K Sell
3,296
-5,165
-61% -$771K 0.11% 128
2023
Q4 		$1.21M Sell
8,461
-22,806
-73% -$3.04M 0.28% 93
2023
Q3 		$4.1M Buy
31,267
+833
+3% +$127K 1.03% 34
2023
Q2 		$4.84M Buy
30,434
+712
+2% +$115K 1.17% 32
2023
Q1 		$4.7M Buy
29,722
+3,186
+12% +$478K 1.19% 30
2022
Q4 		$3.72M Buy
26,536
+5,178
+24% +$735K 0.96% 37
2022
Q3 		$2.74M Buy
21,358
+993
+5% +$143K 0.76% 57
2022
Q2 		$2.87M Buy
20,365
+15,186
+293% +$2.17M 0.8% 58
2022
Q1 		$720K Buy
5,179
+52
+1% +$7.97K 0.16% 113
2021
Q4 		$894K Buy
5,127
+130
+3% +$21.7K 0.19% 113
2021
Q3 		$828K Buy
4,997
+39
+0.8% +$6.72K 0.2% 117
2021
Q2 		$897K Buy
4,958
+3
+0.1% +$548 0.21% 116
2021
Q1 		$956K Buy
4,955
+1,142
+30% +$220K 0.24% 102
2020
Q4 		$770K Buy
+3,813
New +$789K 0.21% 110

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kesler Norman & Wride's CLX Position: Q4 2024 in Review

Kesler Norman & Wride sold out of Clorox (CLX) in Q4 2024, closing a stake of 1,776 shares — an estimated $289K sold.

Kesler Norman & Wride first reported a position in CLX in Q4 2020 and held it in 16 quarters. The position peaked at $4.84M in Q2 2023. 1,222 funds tracked by Wall St. Rank hold CLX as of Q4 2024.

  • Kesler Norman & Wride reported no remaining Clorox position as of Q4 2024 after selling out during the quarter.
  • Kesler Norman & Wride sold 1,776 Clorox shares in Q4 2024, an estimated $289K.
  • Kesler Norman & Wride first reported a position in Clorox in Q4 2020 and held it in 16 quarters.
  • Kesler Norman & Wride's Clorox position peaked at $4.84M in Q2 2023.
  • 1,222 funds tracked by Wall St. Rank held Clorox as of Q4 2024.

Based on Kesler Norman & Wride's 13F filing for Q4 2024, filed 12 Feb 2025.